JBI

JBI JBI is a global organisation promoting and supporting evidence-based decisions that improve health and health service delivery. Better Evidence. Better outcomes.

Brighter future. WHO IS JBI? JBI offers a unique range of solutions to access, appraise and apply the best available evidence. JBI is driven to improving health outcomes in communities globally by promoting and supporting the use of the best available evidence to inform decisions made at the point of care. This work begins and ends with the needs of those working in and using healthcare services. JBI responds to their questions and provides high quality, reliable information that is pragmatic and useful where it counts. This information is based on evidence that is feasible, appropriate, meaningful and effective to specific populations and settings. JBI achieves this by working with universities and hospitals from across the globe through the JBI Collaboration. In doing so JBI ensures that the research evidence we seek to synthesise, transfer and implement is culturally inclusive and relevant across the diversity of healthcare internationally. JBI promotes and supports the sustainability of improved healthcare practice and health outcomes globally by developing and delivering a range of unique evidence-based resources, software, education and training.

🌐 https://jbi.global/about-jbi

OUR VISION
Better evidence. OUR MISSION
Promoting and supporting evidence-based healthcare

WHAT'S THE LATEST BUZZ? JBI BUZZ is JBI's monthly eToC which helps you keep informed about better evidence for better outcomes in healthcare. Subscribe to receive the latest JBI news and links to EBP resources in your inbox.

📧 https://jbi.global/news

09/03/2026

The JBI Model of underpins for systematic reviews. It provides a unifying, conceptual framework recognising diverse forms of evidence and promotes relevant, context-sensitive evidence syntheses directly applicable to practice, policy, and implementation

08/03/2026

👀 SOMETHING EXCITING IS COMING 👀

New discussions. New voices. All from different areas of evidence-based healthcare.

Coming March 2026 ❗

JBI critical appraisal tools use checklists that are specially tailored to different study designs. Because not all heal...
08/03/2026

JBI critical appraisal tools use checklists that are specially tailored to different study designs. Because not all health research questions are about the of an intervention.

Learn more 💡
🔗jbi.global/critical-appraisal-tools

This infographic outlines how to engage knowledge users in the conduct of scoping reviews, giving suggestions for activi...
08/03/2026

This infographic outlines how to engage knowledge users in the conduct of scoping reviews, giving suggestions for activities that can be undertaken to help engage knowledge users throughout the whole process, from planning for knowledge engagement through to sharing scoping review findings.

The infographic is created from the research paper, Moving from consultation to co-creation with knowledge users in scoping reviews: guidance from the JBI Scoping Review Methodology Group at https://ow.ly/2aB850YpZTb

The infographic provides an example of how researchers and knowledge users can co-create and share evidence, and it also shows how knowledge can be made accessible more widely, beyond the published paper, by presenting the information in different formats. The infographic can be downloaded at https://jbi.global/scoping-review-network (go to digital resources)

This International Women's Day, we asked women leading global health and evidence organisations one question: what's the...
08/03/2026

This International Women's Day, we asked women leading global health and evidence organisations one question: what's the most valuable thing you can give as a leader?

Their answers focused on time, belief and space.

Zoe Jordan, Daniela Carl, Laura Boeira, and Ingrid Abdala lead some of the world's most prominent health and evidence organisations. Their reflections have a consistent message: invest in people early, make room for them to grow, and don't wait for someone else to create the culture you want to see.

Read the full piece by Zoe Jordan (JBI), Daniela Carl (G-I-N), Laura Boeira and Ingrid Abdala (Instituto Veredas) at https://ow.ly/rNKW50Yq54q

08/03/2026

Happy International Women's Day! 🌸

This year's theme is a powerful reminder that when we support, empower and believe in women, we all rise together 💗

Our Director, Prof Zoe Jordan, captures this beautifully, reminding us that everything women achieve begins with believing in themselves. When women are supported by the belief of those they work with, that confidence grows and empowers them to achieve more.

This , we celebrate every woman who has dared to believe, and we commit to giving our support, so more women can do the same.

How to develop a robust & detailed scoping review protocol is described in detail, and a checklist for prospective autho...
06/03/2026

How to develop a robust & detailed scoping review protocol is described in detail, and a checklist for prospective authors to ensure their protocols adequately inform the conduct of the review & their readership is included in this paper: https://ow.ly/BTGv50YaETC

We hope this infographic helps those needing to decide whether scoping review methodology is appropriate (or not) for t...
06/03/2026

We hope this infographic helps those needing to decide whether scoping review methodology is appropriate (or not) for their study.

Find step-by-step guidance for conducting scoping reviews at: https://synthesismanual.jbi.global

06/03/2026

Myth: "A scoping review must always include critical appraisal of studies."

Fact: Critical appraisal is optional in scoping reviews. Its inclusion depends on the review aim. Many scoping reviews focus on mapping evidence rather than judging study quality or producing practice recommendations.

Find for conducting scoping reviews at

JBI has developed methodologies for diverse types of evidence synthesis, but where robust methodological guidance alread...
06/03/2026

JBI has developed methodologies for diverse types of evidence synthesis, but where robust methodological guidance already exists, we promote its wider adoption rather than duplicate it. for systematic reviews of prevalence is one of the external methodologies we endorse.

Members of are developing tailored tools and guidance to address key challenges in bias assessment, publication bias, heterogeneity, and meta-analysis of prevalence. Learn more in editorial: https://ow.ly/yW7A50YpyBF

The JBI Manual for Evidence Synthesis can be accessed at: https://ow.ly/C5Gm50YpyBE

05/03/2026

Step-by-step methodological guidance and links to various helpful resources for scoping reviews are in the JBI Manual for Evidence Synthesis at https://ow.ly/9MWN50YaCOJ

05/03/2026

Myth: "Textual evidence is only used when there is no research evidence."

Fact: Textual evidence is not merely a fallback. It can be used as best available evidence or alongside qualitative and quantitative syntheses to inform policy and practice.

Find for systematic reviews of textual evidence: https://ow.ly/RSj150Ypsja

Address

Norwich House, Level 3, 55 King William Road
Adelaide, SA
5006

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when JBI posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Since its inception JBI has strived to provide the best available evidence to inform clinical decision-making at the point of care. The JBI logo is a pebble dropping into water, and is a metaphor for the process of knowledge sharing and practice change and how a single act or piece of information can be a powerful catalyst for continuous change.

Vision

Better evidence. Better outcomes. Brighter future.